Almost weekly, my inbox fills with the same PDF: the school self carry form. One box for “student is capable of carrying and self-administering emergency epinephrine,” one line for my signature, and one implicit assumption that a twelve year old who cannot reliably carry a library book is a competent field medic.
And every day, I sign fewer of them than parents would like. Not because I enjoy conflict, I’m a pediatrician, conflict is my cardio, but because the real world data on self carry is a slow motion comedy, and the punchline is a kid in anaphylaxis standing twenty minutes from the device prescribed to save his life.
The fantasy version
In the fantasy, Aiden feels his throat tighten in the cafeteria, calmly retrieves the auto-injector from his pocket, swings it into his outer thigh, holds it for the correct count, tells an adult, and calls 911. In the fantasy, Aiden has also never lost a water bottle, a retainer, an AirPod, or an entire winter coat.
In the fantasy, “self-carry” means the medicine is always within reach. In reality, “self-carry” means the medicine is wherever Aiden last set it down, which is a location known to no living person.
The documented version
Let’s go to the tape. In a population based Australian study of 10 to 14 year olds with likely IgE-mediated food allergy who had been prescribed an adrenaline auto-injector, 93% had dutifully given a device and action plan to the school, the boring, institutional, nurse in the office model everyone finds so insulting. Meanwhile, 49% of those same students never carried their device in at least one setting. Never. Not “sometimes forgot.” Never.
Where did it collapse?
Precisely where parents aren’t watching. Thirty two percent never carried it when they were by themselves. Twenty eight percent never carried it out with friends. Thirty six percent never carried it to sporting activities, the exact combination of exertion, shared snacks, and adolescent bravado that anaphylaxis enjoys most.
So the supervised setting achieves 93% availability, and the unsupervised setting achieves “define availability.” And the form in my hand proposes we solve this by moving the device from the first category into the second. Bold.
US survey data are no more flattering.
Among patients and parents of children and adolescents prescribed an auto-injector, 89% filled the prescription, congratulations, the pharmacy step works, but only 44% carried at least one device “all the time,” and just 24% carried more than one. That matters, because one device is frequently not enough: reactions escalate, doses fail, needles bend in denim.
Then comes the part that should end most self carry debates on the spot. Over half of adults reported that epinephrine was not used during their most severe reaction even though it would have helped. The single most common reason given by people who owned an auto-injector and didn’t use it? It wasn’t available. Not “I panicked.” Not “I misread the symptoms.” The pen and the patient were in different ZIP codes.
But surely the ones who have it use it correctly.
Adorable question. In a pediatric food-allergy cohort, 72% of children’s most severe lifetime reactions were severe enough to warrant epinephrine, and the auto-injector was actually used in 38% of them. Roughly three of every five reactions that called for epinephrine got something else instead: an antihistamine, a wait and see, a car ride, a prayer.
And correct technique, measured by observation rather than self-flattery, has been reported in the range of 16% to 32%. Read that again slowly, then remember that these are motivated families who own the device. If 68% to 84% of trained users fumble the four steps in a calm exam room, I’m not thrilled about the version performed on a bus, in the dark, mid-hives, by a seventh grader whose friends are filming it.
Let me be clear about what those three numbers add up to: kids often don’t have the auto-injector, frequently don’t use it when they should, and when they do use it, technique is a coin flip weighted against them. Self-carry isn’t a plan. It’s a hope with paperwork.
Why parents want the form anyway
Because self carry sounds like independence, and independence sounds like good parenting. Because the nurse’s office is across campus. Because a previous doctor signed it without reading it. Because your child is, and I say this sincerely, unusually responsible, as is every child, according to every parent, in the history of medicine.
And sometimes the request is right. A sixteen-year-old who drives, works, carries the device in a fitted waist pouch, can demonstrate all four steps twice without coaching, has a documented history of using it promptly, and has a backup dose in the nurse’s office is a genuinely good candidate. Notice how much work that sentence did. Notice that “backup in the office” stayed in.
What I actually do with the form
I might sign it in a specific shape: As in the scenario above, self-carry plus a second device stored with the school, a written action plan on file, staff trained to administer, and a plan that assumes the child will freeze, because freezing is the modal outcome, not the exception. Belt, suspenders, and a spare belt in the office.
I decline the version where the school device disappears and the entire safety plan rests on a pocket. That’s not autonomy. That’s outsourcing a life threatening emergency to the least experienced person in the room while removing the backup.
Here’s the part nobody wants printed on the form: the right answer is usually both. Carriage where feasible, institutional supply ALWAYS. The data don’t show that teenagers are irresponsible. They show that teenagers are teenagers, that adults misuse these devices too, and that a medication which works only when physically present should therefore be present in more than one place.
Anaphylaxis doesn’t care about your family’s values around independence. It cares about milligrams, minutes, and whether the pen is in the building. I’d rather your child be mildly annoyed about redundancy at 14 than perfectly autonomous and twenty minutes from a dose.
So yes, ask me to sign it. I’ll read it first, and I’ll almost certainly add a line. Consider the line a love letter, from the only person in the exam room who has read the carriage data and still has to sleep at night.
Any advice or information given in this blog should not supersede consultation with your pediatrician or practitioner of choice. Every child is unique, and medical decisions must be made in partnership with the healthcare provider who knows your child’s full history. This blog is intended for educational and informational purposes only, not as a substitute for personalized medical care.If you are looking for medical advice that is evidence-based, ethically grounded, and uncompromised by industry influence, you are in the right place.
Sources:
Robinson M, Koplin JJ, Field MJ, et al; School Nuts Investigators. Patterns of Carriage of Prescribed Adrenaline Autoinjectors in 10- to 14-Year-Old Food-Allergic Students: A Population-Based Study. J Allergy Clin Immunol Pract. 2019;7(2):437-443. doi:10.1016/j.jaip.2018.06.025. https://pubmed.ncbi.nlm.nih.gov/30031901/
Warren CM, Zaslavsky JM, Kan K, Spergel JM, Gupta RS. Epinephrine auto-injector carriage and use practices among US children, adolescents, and adults. Ann Allergy Asthma Immunol. 2018;121(4):479-489.e2. doi:10.1016/j.anai.2018.06.010. https://pubmed.ncbi.nlm.nih.gov/29936229/
Glassberg B, Nowak-Węgrzyn A, Wang J. Factors contributing to underuse of epinephrine autoinjectors in pediatric patients with food allergy. Ann Allergy Asthma Immunol. 2021;126(2):175-179.e3. doi:10.1016/j.anai.2020.09.012. https://pmc.ncbi.nlm.nih.gov/articles/PMC7498408/